MYRIAD MALADIES
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The endoplasmic reticulum performs the initial processing of newly synthesized lysosomal enzymes
The Golgi apparatus further processes and labels specific enzymes for delivery to the lysosome Within the lysosome, enzymes convert molecules such as sugars, proteins and lipids into simpler building blocks
The autophagosome delivers damaged organelles and misfolded proteins to the lysosome for recycling Endosomes transport enzymes from the Golgi and materials from outside the cell to the lysosome Molecular building blocks are released into cell for reuse
COLLECTIVELY COMMON, INDIVIDUALLY RARE
LSDs are not especially rare; estimates suggest that 1 in just over 5,000 newborns will be affected. However, each individual disease occurs with much lower frequency -the most common, Gaucher's disease, affects only 1 in 40,000 newborns worldwide, and the rarest have been described only a handful of times. The diseases shown are those for which there are most data. Numbers have been estimated and are approximate.
MANY MOVING PARTS
The lysosome uses specialized enzymes to help cells to digest external biological materials and recycle defective proteins and damaged cellular machinery. Many LSDs arise from mutations in the genes that encode those enzymes, but there are numerous other ways in which this process can break down (red stars). Chaperone therapy protects or refolds mutant enzymes. This prevents them from being degraded in the endoplasmic reticulum and ejected, and allows them to reach the lysosome.
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In gene therapy, a functional replacement enzyme-producing gene is delivered using a vector such as a virus. This technology is still being developed (page S158).
THE LONG ROAD TO DISCOVERY
The first LSDs were identified more than 80 years before researchers were able to identify the cellular structures involved. Since then, new LSDs have been identified along with, more recently, the genes involved and drugs that help to repair the damage.
POTENTIAL ROADS TO RECOVERY
The past 25 years have seen considerable progress in the development of treatments that can improve the quality of life for some patients. Most treatments focus on changing intracellular processes. The exception is bone-marrow transplant, in which the patient receives an entire set of healthy stem cells from a suitable donor. 
BONE-MARROW TRANSPLANT
